LBL Chart by TradingView

Business Description

Lattice Biologics Ltd. (“Lattice”, “company”), based out of Scottsdale, Arizona, is an emerging player in the field of natural and regenerative tissue engineering for bone, skin, and cartilage, as well as novel products related to cancer diagnostics.


FRC Analyst's Reports

Lattice Biologics (TSXV: LBL / OTCBB: BLVKF): Strengthens Pipeline Sep. 7, 2016
Lattice Biologics (TSXV: LBL) New product sales growing Jun. 6, 2016
Lattice Biologics (TSXV: LBL / OTCBB: BLVKF): Initiating; Regenerative Medicine May. 11, 2016


Lattice Biologics Ltd. Reports Second Quarter 2021 Results and Resumes Trading Jul. 9, 2021
IIROC Trading Halt – LBL Jun. 7, 2021
Lattice Announces Strategic Advisory Board Mar. 31, 2021
Lattice Announces Strategic Cannabis Supply Agreement With Firehouse Mar. 19, 2021
Lattice Biologics Reorganizes to Focus on Psychedelics and Cannabis Therapies Mar. 15, 2021

Investors are also interested in these companies: